Skeletal Dysplasia Account Manager - Charlotte, NC

What You Will Do
- Launch Infigratinib (first-in-class therapy for achondroplasia) in the Southeast region with deep clinical acumen and partnership with providers and families.

Responsibilities
- Develop and execute a territory business plan to target geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and skeletal dysplasia clinic teams; meet/exceed sales goals.
- Demonstrate deep expertise in Infigratinib, achondroplasia, and skeletal dysplasia; engage HCPs in clinically relevant, compliant discussions.
- Use sales/target data to identify growth opportunities and proactively address territory challenges.
- Anticipate challenges, adjust priorities, and develop solutions.
- Partner compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer/family satisfaction.
- Build KOL relationships with Marketing and Medical Affairs to expand advocacy.
- Maintain exceptional proficiency in selling skills and product/clinical/market knowledge.
- Ensure all activities comply with regulations, company policies, and Pharma guidelines.

Qualifications
- 8–10 years pharmaceutical/biotech; 4+ years in rare/genetic/skeletal dysplasia (achondroplasia or pediatric rare disease strongly preferred).
- BS/BA required; MBA a plus.
- Extensive travel.
- Product/indication launch experience; account management success.
- Strong communication/influence, accountability, judgment, and organizational skills.
- AI fluency (curiosity/adaptability with AI tools).
- Integrity and commitment to ethical/compliance culture.